The Impact of Prenatal Exposure to Dexamethasone on Gastrointestinal Function in Rats.

Antenatal treatment with synthetic glucocorticoids is commonly used in pregnant women at risk of preterm delivery to accelerate tissue maturation. Exposure to glucocorticoids during development has been hypothesized to underlie different functional gastrointestinal (GI) and motility disorders. Herei...

Full description

Bibliographic Details
Main Authors: Fátima Ramalhosa, Carina Soares-Cunha, Rui Miguel Seixal, Nuno Sousa, Ana Franky Carvalho
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5008745?pdf=render
id doaj-30c00ce26fb545e78cf8b19c7753dd09
record_format Article
spelling doaj-30c00ce26fb545e78cf8b19c7753dd092020-11-25T02:13:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01119e016175010.1371/journal.pone.0161750The Impact of Prenatal Exposure to Dexamethasone on Gastrointestinal Function in Rats.Fátima RamalhosaCarina Soares-CunhaRui Miguel SeixalNuno SousaAna Franky CarvalhoAntenatal treatment with synthetic glucocorticoids is commonly used in pregnant women at risk of preterm delivery to accelerate tissue maturation. Exposure to glucocorticoids during development has been hypothesized to underlie different functional gastrointestinal (GI) and motility disorders. Herein, we investigated the impact of in utero exposure to synthetic glucocorticoids (iuGC) on GI function of adult rats. Wistar male rats, born from pregnant dams treated with dexamethasone (DEX), were studied at different ages. Length, histologic analysis, proliferation and apoptosis assays, GI transit, permeability and serotonin (5-HT) content of GI tract were measured. iuGC treatment decreased small intestine size and decreased gut transit. However, iuGC had no impact on intestinal permeability. iuGC differentially impacts the structure and function of the GI tract, which leads to long-lasting alterations in the small intestine that may predispose subjects prone to disorders of the GI tract.http://europepmc.org/articles/PMC5008745?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Fátima Ramalhosa
Carina Soares-Cunha
Rui Miguel Seixal
Nuno Sousa
Ana Franky Carvalho
spellingShingle Fátima Ramalhosa
Carina Soares-Cunha
Rui Miguel Seixal
Nuno Sousa
Ana Franky Carvalho
The Impact of Prenatal Exposure to Dexamethasone on Gastrointestinal Function in Rats.
PLoS ONE
author_facet Fátima Ramalhosa
Carina Soares-Cunha
Rui Miguel Seixal
Nuno Sousa
Ana Franky Carvalho
author_sort Fátima Ramalhosa
title The Impact of Prenatal Exposure to Dexamethasone on Gastrointestinal Function in Rats.
title_short The Impact of Prenatal Exposure to Dexamethasone on Gastrointestinal Function in Rats.
title_full The Impact of Prenatal Exposure to Dexamethasone on Gastrointestinal Function in Rats.
title_fullStr The Impact of Prenatal Exposure to Dexamethasone on Gastrointestinal Function in Rats.
title_full_unstemmed The Impact of Prenatal Exposure to Dexamethasone on Gastrointestinal Function in Rats.
title_sort impact of prenatal exposure to dexamethasone on gastrointestinal function in rats.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description Antenatal treatment with synthetic glucocorticoids is commonly used in pregnant women at risk of preterm delivery to accelerate tissue maturation. Exposure to glucocorticoids during development has been hypothesized to underlie different functional gastrointestinal (GI) and motility disorders. Herein, we investigated the impact of in utero exposure to synthetic glucocorticoids (iuGC) on GI function of adult rats. Wistar male rats, born from pregnant dams treated with dexamethasone (DEX), were studied at different ages. Length, histologic analysis, proliferation and apoptosis assays, GI transit, permeability and serotonin (5-HT) content of GI tract were measured. iuGC treatment decreased small intestine size and decreased gut transit. However, iuGC had no impact on intestinal permeability. iuGC differentially impacts the structure and function of the GI tract, which leads to long-lasting alterations in the small intestine that may predispose subjects prone to disorders of the GI tract.
url http://europepmc.org/articles/PMC5008745?pdf=render
work_keys_str_mv AT fatimaramalhosa theimpactofprenatalexposuretodexamethasoneongastrointestinalfunctioninrats
AT carinasoarescunha theimpactofprenatalexposuretodexamethasoneongastrointestinalfunctioninrats
AT ruimiguelseixal theimpactofprenatalexposuretodexamethasoneongastrointestinalfunctioninrats
AT nunosousa theimpactofprenatalexposuretodexamethasoneongastrointestinalfunctioninrats
AT anafrankycarvalho theimpactofprenatalexposuretodexamethasoneongastrointestinalfunctioninrats
AT fatimaramalhosa impactofprenatalexposuretodexamethasoneongastrointestinalfunctioninrats
AT carinasoarescunha impactofprenatalexposuretodexamethasoneongastrointestinalfunctioninrats
AT ruimiguelseixal impactofprenatalexposuretodexamethasoneongastrointestinalfunctioninrats
AT nunosousa impactofprenatalexposuretodexamethasoneongastrointestinalfunctioninrats
AT anafrankycarvalho impactofprenatalexposuretodexamethasoneongastrointestinalfunctioninrats
_version_ 1724905919432622080